These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28130102)

  • 21. Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases.
    Samaratunga H; Delahunt B; Srigley JR; Yaxley J; Johannsen S; Coughlin G; Gianduzzo T; Kua B; Patterson I; Nacey JN; Egevad L
    Histopathology; 2017 Oct; 71(4):641-647. PubMed ID: 28590015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
    Han M; Pound CR; Potter SR; Partin AW; Epstein JI; Walsh PC
    J Urol; 2001 Mar; 165(3):864-6. PubMed ID: 11176487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.
    Donohue JF; Bianco FJ; Kuroiwa K; Vickers AJ; Wheeler TM; Scardino PT; Reuter VA; Eastham JA
    J Urol; 2006 Sep; 176(3):991-5. PubMed ID: 16890678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
    Heidenreich A; Pfister D; Porres D
    J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.
    Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H
    J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart.
    Ko J; Falzarano SM; Walker E; Streator Smith K; Stephenson AJ; Klein EA; Magi-Galluzzi C
    Prostate; 2013 Jun; 73(8):897-903. PubMed ID: 23280623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer.
    Ramos CG; Roehl KA; Antenor JA; Humphrey PA; Catalona WJ
    J Urol; 2004 Jul; 172(1):137-40. PubMed ID: 15201754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
    Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do younger men have better biochemical outcomes after radical prostatectomy?
    Freedland SJ; Presti JC; Kane CJ; Aronson WJ; Terris MK; Dorey F; Amling CL;
    Urology; 2004 Mar; 63(3):518-22. PubMed ID: 15028449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucinous and secondary tumors of the prostate.
    Osunkoya AO
    Mod Pathol; 2018 Jan; 31(S1):S80-S95. PubMed ID: 29297488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
    Loeb S; Zhu X; Schroder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1678-83. PubMed ID: 22998182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea.
    Kim JK; Cho SY; Jeong CW; Lee SB; Ku JH; Hong SK; Byun SS; Kwak C; Him HH; Lee SE; Jeong H
    BJU Int; 2012 Aug; 110(4):505-9. PubMed ID: 22314007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.
    Kattan MW; Wheeler TM; Scardino PT
    J Clin Oncol; 1999 May; 17(5):1499-507. PubMed ID: 10334537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.
    Mitchell CR; Boorjian SA; Umbreit EC; Rangel LJ; Carlson RE; Karnes RJ
    BJU Int; 2012 Dec; 110(11):1709-13. PubMed ID: 22934913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study.
    Holmström B; Holmberg E; Egevad L; Adolfsson J; Johansson JE; Hugosson J; Stattin P;
    J Urol; 2010 Oct; 184(4):1322-7. PubMed ID: 20723940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
    Richstone L; Bianco FJ; Shah HH; Kattan MW; Eastham JA; Scardino PT; Scherr DS
    BJU Int; 2008 Mar; 101(5):541-6. PubMed ID: 18257855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
    Sokoll LJ; Zhang Z; Chan DW; Reese AC; Bivalacqua TJ; Partin AW; Walsh PC
    J Urol; 2016 Feb; 195(2):330-6. PubMed ID: 26307160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing nature of high risk patients undergoing radical prostatectomy.
    Kane CJ; Presti JC; Amling CL; Aronson WJ; Terris MK; Freedland SJ;
    J Urol; 2007 Jan; 177(1):113-7. PubMed ID: 17162017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.